Du är här

2015-09-22

Prothena Corporation plc: Prothena to Present at Ladenburg Thalmann 2015 Healthcare Conference on September 29

--------------------------------------------------------------------------------
| DUBLIN, Ireland, Sept. 22, 2015 (GLOBE NEWSWIRE) -- Prothena Corporation plc |
|(NASDAQ:PRTA), a late-stage clinical biotechnology company focused on the |
|discovery, development and commercialization of novel protein |
|immunotherapies, today announced that members of the senior management team |
|will present and participate in investor meetings at the Ladenburg Thalmann |
|2015 Healthcare Conference on September 29 at 1:00 PM EDT at The Sofitel |
|Hotel in New York, NY. |
| |
| |
|A live webcast of the presentation can be accessed through the investor |
|relations section of the Company's website atwww.prothena.com. Following the |
|live presentation, replays of the webcasts will be available on the Company's |
|website for 90 days following the presentation date. |
| |
| |
|About Prothena |
| |
| |
| |
|Prothena Corporation plc is a late-stage clinical biotechnology company |
|focused on the discovery, development and commercialization of novel protein |
|immunotherapy programs for the potential treatment of diseases that involve |
|amyloid or cell adhesion. The company is developing antibody-based product |
|candidates that target a number of potential indications including AL |
|amyloidosis (NEOD001), Parkinson's disease and other related |
|synucleinopathies (PRX002), and psoriasis and other inflammatory diseases |
|(PRX003). |
| |
|For more information, please visit the company's web site |
|atwww.prothena.com.CONTACT: Investors: Tran Nguyen, CFO |
| 650-837-8535, IR@prothena.com |
| |
| Media: Ellen Rose |
| 650-922-2405, ellen.rose@prothena.com |
--------------------------------------------------------------------------------

---------------------------------------

This announcement is distributed by NASDAQ OMX Corporate Solutions on behalf of NASDAQ OMX Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Prothena Corporation plc via Globenewswire

HUG#1952618

Författare Hugin

Tala om vad ni tycker

Tala om vad ni tycker

Ni är just nu inne på en betaversion av nya aktiespararna. Lämna gärna feedback på vad ni tycker i formuläret nedan.